Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARROW, INC. Director's Dealing 2020

Mar 18, 2020

31774_dirs_2020-03-18_2c043c25-1590-41d7-93fb-a30d9bd8ea38.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2020-03-16

Reporting Person: AUSTIN STEPHEN G (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-03-16 COMMON STOCK M 72218 Acquired 91987 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-03-16 RSU $0 M 9715 Disposed Common Stock (9715) Direct
2020-03-16 RSU $0 M 34091 Disposed Common Stock (34091) Direct
2020-03-16 RSU $0 M 15723 Disposed Common Stock (15723) Direct
2020-03-16 RSU $0 M 12690 Disposed Common Stock (12690) Direct

Footnotes

F1: The Reporting Person was awarded Restricted Stock Units for his service as director of the Company that vested quarterly in equal installments over a one-year periods following the date of grant. The shares underlying such Restricted Stock Units were deferred to the Reporting Person until his resignation from the Company's board of directors.

F2: The Restricted Stock Units were received as a compensatory award for no consideration.